Adma Biologics (ADMA) EBT Margin (2011 - 2025)
Adma Biologics (ADMA) reported EBT Margin of 44.26% for Q4 2025, up 1473.0% on a YoY basis from 2.81% in Q4 2024, and up 25.03% quarter-over-quarter from 35.4% in Q3 2025.
Adma Biologics (ADMA) EBT Margin (2011 - 2025) Analysis & Trends
Adma Biologics has reported EBT Margin for 13 years, with the latest figure at 44.26% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 1473.0% year-over-year to 44.26%; the trailing twelve-month figure through Dec 2025 stood at 35.8% (up 632.0% YoY), and the FY2025 full-year result was 35.8%, up 632.0% from the prior year.
- EBT Margin for Q4 2025 stood at 44.26%, up from 35.4% in the prior quarter.
- The five-year high for EBT Margin was 44.26% in Q4 2025, with the low at 114.26% in Q1 2021.
- Historically, EBT Margin has averaged 11.21% across 5 years, with a median of 4.13% in 2023.
- Annual changes were most pronounced in 2021 — EBT Margin surged 11552 bps — and 2025, when it plunged 58 bps.
- Adma Biologics' EBT Margin stood at 30.01% in 2021, then increased by 21 bps to 23.59% in 2022, then soared by 161 bps to 14.33% in 2023, then jumped by 106 bps to 29.53% in 2024, then soared by 50 bps to 44.26% in 2025.
- The last three EBT Margin figures came in at 44.26% (Q4 2025), 35.4% (Q3 2025), and 32.87% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 44.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.26% |
| Sep 30, 2025 | 35.40% |
| Jun 30, 2025 | 32.87% |
| Mar 31, 2025 | 29.14% |
| Dec 31, 2024 | 29.53% |
| Sep 30, 2024 | 30.67% |
| Jun 30, 2024 | 33.45% |
| Mar 31, 2024 | 22.47% |
| Dec 31, 2023 | 14.33% |
| Sep 30, 2023 | 2.33% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -11.93% |
| Dec 31, 2022 | -23.59% |
| Sep 30, 2022 | -36.24% |
| Jun 30, 2022 | -18.33% |
| Mar 31, 2022 | -62.44% |
| Dec 31, 2021 | -30.01% |
| Sep 30, 2021 | -85.74% |
| Jun 30, 2021 | -105.56% |
| Mar 31, 2021 | -114.26% |